UNSPSC 85212202: Diagnosis of tuberculosis of lung, without mention of bacteriological or histological confirmation

This classification denotes the group of activities that yields a diagnosis of Tuberculosis of lung, without mention of bacteriological or histological confirmation. Tuberculosis of lung, without mention of bacteriological or histological confirmation is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code A16. 2

UNSPSC 85212202 Diagnosis of tuberculosis of lung, without mention of bacteriological or histological confirmation is a Commodity code that appears to be a medical diagnostic classification used in clinical settings, but the recent state and local solicitations tagged under it do not reflect tuberculosis-specific diagnostic work. Instead, the posted opportunities concern broader diagnostic imaging infrastructure, specialized health professional staffing, and special education services — a mismatch suggesting this code may be misapplied in the underlying procurement systems. The scope of work actually being solicited does not align with the nominal tuberculosis-diagnosis description; the code shows little relevant recent activity for TB diagnostics specifically.

The issuing bodies in the recent opportunities block are a county hospital system (San Mateo Medical Center), a school district (Birdville Independent School District in Texas), and a county health system (Santa Clara Health System in California). The opportunities range from an RFP for diagnostic imaging PACS infrastructure with an October 21, 2026 due date, to a special education contracted services RFP also due October 21, 2026, to a non-exclusive multiple-award vendor qualification vehicle for temporary health professional staffing due October 7, 2026. Geographic activity spans California (San Mateo County and Santa Clara County) and Texas (Tarrant County), but the code's actual use in state and local procurement does not map clearly to TB diagnosis work, and available data does not support actionable market characterization for this specific diagnostic scope.